Kentaro Yamazaki

Kentaro Yamazaki

UNVERIFIED PROFILE

Are you Kentaro Yamazaki?   Register this Author

Register author
Kentaro Yamazaki

Kentaro Yamazaki

Publications by authors named "Kentaro Yamazaki"

Are you Kentaro Yamazaki?   Register this Author

100Publications

2667Reads

32Profile Views

Adherence to a topical moisturizing preparation for regorafenib-related hand-foot skin reaction.

J Oncol Pharm Pract 2019 May 19:1078155219849275. Epub 2019 May 19.

1 Department of Pharmacy, Shizuoka Cancer Center, Nagaizumi, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155219849275DOI Listing
May 2019

Phase II study of S-1 plus oxaliplatin 130 mg/m in Japanese patients with advanced gastric cancer.

Int J Clin Oncol 2018 Dec 21;23(6):1084-1089. Epub 2018 Jun 21.

Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-018-1308-1DOI Listing
December 2018

Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials.

J Glob Oncol 2018 07;4:1-12

Chia-Jui Yen, National Cheng Kung University Hospital, Tainan; Jin-Yuan Shih, National Taiwan University Hospital; Yee Chao, National Yang-Ming University and Taipei Veterans General Hospital; Rebecca Cheng, Eli Lilly and Company, Taipei, Taiwan; Kei Muro, Aichi Cancer Center Hospital, Nagoya; Masatoshi Kudo, Kindai University School of Medicine, Osaka-Sayama City, Osaka; Kentaro Yamazaki, Shizuoka Cancer Center, Shizuoka, Japan; Tae-Won Kim and Sang-We Kim, Asan Medical Center; JooHyuk Sohn and Hyun Cheol Chung, Yonsei University College of Medicine, Seoul; Keun-Wook Lee, Seoul National University College of Medicine, Seongnam, South Korea; Yawei Zhang and Polina Binder, Eli Lilly and Company, Bridgewater, NJ; Gu Mi, Eli Lilly and Company, Indianapolis, IN, USA; and Mauro Orlando, Eli Lilly and Company, Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.17.00227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223521PMC
July 2018

Role of hepatectomy in gastric cancer with multiple liver-limited metastases.

Gastric Cancer 2018 Mar 2;21(2):338-344. Epub 2017 Jun 2.

Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo Nagaizumi-cho Sunto-gun, Shizuoka, 411-8777, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-017-0730-9DOI Listing
March 2018

[II. Clinical Guidelines of Molecular Testing for Colorectal Cancer].

Gan To Kagaku Ryoho 2017 Nov;44(11):990-994

Division of Gastrointestinal Oncology, Shizuoka Cancer Center.

View Article

Download full-text PDF

Source
November 2017

Current status and future perspective of the chemotherapy for colorectal cancer.

Nihon Rinsho 2016 11;74(11):1852-1856

View Article

Download full-text PDF

Source
November 2016

[I. Immune Checkpoint Inhibitors in Colorectal Cancer].

Gan To Kagaku Ryoho 2016 Nov;43(11):1347-1351

Division of Gastrointestinal Oncology, Shizuoka Cancer Center.

View Article

Download full-text PDF

Source
November 2016

12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study.

J Clin Oncol 2016 08 20;34(24):2906-13. Epub 2016 Jun 20.

Takeharu Yamanaka, National Cancer Center; Atsushi Ochiai, Atsushi Ohtsu, and Takayuki Yoshino, National Cancer Center Hospital East Chiba, Japan; Takeharu Yamanaka, Yokohama City University, Yokohama; Eiji Oki, Kyushu University; Tetsuya Kusumoto, National Kyushu Medical Center, Fukuoka; Kentaro Yamazaki, Shizuoka Cancer Center, Shizuoka; Kensei Yamaguchi and Kiwamu Akagi, Saitama Cancer Center, Saitama; Kensei Yamaguchi, Cancer Institute Hospital of Japanese Foundation for Cancer Research; Hiroyuki Uetake, Tokyo Medical and Dental University; Yasuo Ohashi, Chuo University, Tokyo; Kei Muro, Aichi Cancer Center Hospital, Nagoya; Takeo Sato, Kitasato University School of Medicine, Kanagawa; Tomohiro Nishina, National Hospital Organization Shikoku Cancer Center, Matsuyama; Masataka Ikeda, Osaka National Hospital; Akiyoshi Kanazawa, Kitano Hospital, Osaka; Takeshi Kato, Kansai Rosai Hospital, Amagasaki, Japan; Calvin Chao, Margarita Lopatin, Jayadevi Krishnakumar, and Helen Bailey, Genomic Health, Redwood City, CA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.0414DOI Listing
August 2016

Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapy.

Gastric Cancer 2016 Jul 11;19(3):894-901. Epub 2015 Sep 11.

Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Shizuoka, 411-8777, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-015-0540-xDOI Listing
July 2016

The art of traditional native PAGE: The APLP 48-ID assay for human identification.

Leg Med (Tokyo) 2016 Mar 21;19:28-31. Epub 2015 Dec 21.

Department of Forensic Medicine, Yamagata University School of Medicine, Yamagata 990-9585, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.legalmed.2015.12.006DOI Listing
March 2016

An In Vitro System Comprising Immortalized Hypothalamic Neuronal Cells (GT1-7 Cells) for Evaluation of the Neuroendocrine Effects of Essential Oils.

Evid Based Complement Alternat Med 2015 21;2015:343942. Epub 2015 Oct 21.

Research Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Musashino University, 1-1-20 Shin-machi, Nishitokyo-shi, Tokyo 202-8585, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/343942DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631885PMC
November 2015

Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer.

Invest New Drugs 2015 Oct 12;33(5):1068-77. Epub 2015 Jul 12.

Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-015-0271-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768213PMC
October 2015

A phase II study of S-1, oxaliplatin, oral leucovorin, and bevacizumab combination therapy (SOLA) in patients with unresectable metastatic colorectal cancer.

Cancer Chemother Pharmacol 2015 Sep 22;76(3):547-53. Epub 2015 Jul 22.

Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, 160 Minami Umemoto-machi Kou, Matsuyama, 791-0280, Japan,

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs00280-015-28
Web Search
http://link.springer.com/10.1007/s00280-015-2825-5
Publisher Site
http://dx.doi.org/10.1007/s00280-015-2825-5DOI Listing
September 2015

[Targeted therapies for metastatic colorectal cancer].

Nihon Rinsho 2015 Aug;73(8):1384-90

View Article

Download full-text PDF

Source
August 2015

Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations.

Invest New Drugs 2015 Jun 12;33(3):740-50. Epub 2014 Sep 12.

Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, 277-8577, Chiba, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-014-0154-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434855PMC
June 2015

Randomized trial of TAS-102 for refractory metastatic colorectal cancer.

N Engl J Med 2015 May;372(20):1909-19

From the Dana-Farber Cancer Institute, Boston (R.J.M, J.M.C.); University Hospitals, Leuven and KU Leuven, Leuven (E.V.C., H.P.), and Universitaire Ziekenhuizen Antwerp, Edegem (M.P.) - all in Belgium; University of Pisa, Pisa (A.F.), IRCCS Azienda Ospedaliera Universitaria San Martino-Istituto Nazionale per la Ricerca Sul Cancro, Genoa (A.S.), and the Fondazione Poliambulanza Istituto Ospedaliero, Brescia (A.Z.) - all in Italy; National Cancer Center Hospital East, Chiba (T.Y., A.O.), Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo (N.M.), Shizuoka Cancer Center, Shizuoka (K.Y.), National Cancer Center Hospital, Tokyo (Y.S.), Hokkaido University Hospital, Hokkaido (Y.K.), and Taiho Pharmaceutical, Tokyo (M.I.) - all in Japan; Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Seville (R.G.-C.), and Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona (J.T.) - all in Spain; Centre Eugène Marquis, Rennes, France (E.B.); Royal Melbourne Hospital, Melbourne, VIC, Australia (B.T.); University of Southern California Norris Comprehensive Cancer Center, Los Angeles (H.-J.L.); Yale Cancer Center, New Haven, CT (H.H.); Taiho Oncology, Princeton, NJ (F.B., H.M.); and Stathmi, New Hope, PA (L.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1414325DOI Listing
May 2015

Influence of primary tumor resection on survival in asymptomatic patients with incurable stage IV colorectal cancer.

Int J Clin Oncol 2014 Dec 15;19(6):1037-42. Epub 2014 Feb 15.

Division of Colon and Rectal Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-877, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-014-0662-xDOI Listing
December 2014

An N-acetyllactosamine-specific lectin, PFA, isolated from a moth (Phalera flavescens), structurally resembles an invertebrate-type lysozyme.

Insect Biochem Mol Biol 2014 Nov 23;54:106-11. Epub 2014 Sep 23.

Department of Forensic Medicine, Yamagata University School of Medicine, 2-2-2 Iidanishi, Yamagata 990-9585, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ibmb.2014.09.005DOI Listing
November 2014

Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors.

Cancer Chemother Pharmacol 2014 Sep 25;74(3):629-36. Epub 2014 Jul 25.

National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-014-2521-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143601PMC
September 2014

Phase I study of Efatutazone, an oral PPARγ agonist, in patients with metastatic solid tumors.

Anticancer Res 2014 Sep;34(9):5133-41

Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/content/34/9/5133.full.pdf
Web Search
September 2014

Determination of prognostic factors in Japanese patients with advanced gastric cancer using the data from a randomized controlled trial, Japan clinical oncology group 9912.

Oncologist 2014 Apr 25;19(4):358-66. Epub 2014 Mar 25.

Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan; Department of Clinical Oncology, St. Marianna University School of Medicine, Kanagawa, Japan; JCOG Data Center, Multi-institutional Clinical Trial Support Center, National Cancer Center, Tokyo, Japan; Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan; Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan; Department of Gastroenterology, Yamagata Prefectural Central Hospital, Yamagata, Japan; Department of Gastroenterology, Saitama Cancer Center Hospital, Saitama, Japan; Cancer Chemotherapy Center, Osaka Medical College, Takatsuki, Japan; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan; Division of Diabetes, Digestive and Kidney Diseases, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan; Division of Medical Oncology, Kochi Health Sciences Center, Kochi, Japan.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2013-0306DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983816PMC
April 2014

[I. Molecular targeted therapy for unresectable wild type K-ras recurrent colon cancer].

Gan To Kagaku Ryoho 2013 Nov;40(11):1456-8

View Article

Download full-text PDF

Source
November 2013

A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancer.

Invest New Drugs 2013 Aug 20;31(4):910-7. Epub 2012 Nov 20.

Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwashi, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-012-9895-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717157PMC
August 2013

KRAS mutational status in Japanese patients with colorectal cancer: results from a nationwide, multicenter, cross-sectional study.

Jpn J Clin Oncol 2013 Jul 8;43(7):706-12. Epub 2013 May 8.

Department of Surgical Oncology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyt062DOI Listing
July 2013

Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients.

Int J Clin Oncol 2013 Apr 25;18(2):279-84. Epub 2012 Feb 25.

Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-012-0374-zDOI Listing
April 2013

Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy.

J Cancer Res Clin Oncol 2013 Apr 19;139(4):595-603. Epub 2012 Dec 19.

Department of Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-012-1349-1DOI Listing
April 2013

Clinical outcome of Japanese metastatic colorectal cancer patients harbouring the KRAS p.G13D mutation treated with cetuximab + irinotecan.

Jpn J Clin Oncol 2012 Dec 15;42(12):1146-51. Epub 2012 Oct 15.

Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hys160DOI Listing
December 2012

Factors that prolong the 'postmortem interval until finding' (PMI-f) among community-dwelling elderly individuals in Japan: analysis of registration data.

BMJ Open 2012 27;2(5). Epub 2012 Sep 27.

Department of Health Services Research, Doctoral Program in Human Care Science, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjopen-2012-001280DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488755PMC
October 2012

Leptomeningeal carcinomatosis associated with gastric cancer.

Int J Clin Oncol 2012 Aug 17;17(4):361-6. Epub 2011 Aug 17.

Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-011-0301-8DOI Listing
August 2012

Bacterial species-characteristic profiles of molecular species, and the antigenicity of phospholipids and glycolipids in symbiotic Lactobacillus, Staphylococcus and Streptococcus species.

Glycoconj J 2012 May 26;29(4):199-209. Epub 2012 May 26.

Department of Biochemistry, Faculty of Science and Technology, Kinki University, 3-4-1 Kowakae, Higashiosaka, Osaka, 577-8502, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10719-012-9393-2DOI Listing
May 2012

Safety, efficacy and pharmacokinetics of neratinib (HKI-272) in Japanese patients with advanced solid tumors: a Phase 1 dose-escalation study.

Jpn J Clin Oncol 2012 Apr 27;42(4):278-86. Epub 2012 Feb 27.

Breast Cancer Division, Department of Medical Oncology, The Cancer Institute of the Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hys012DOI Listing
April 2012

Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancer.

Anticancer Res 2012 Mar;32(3):973-9

6-5-1, Kashiwanoha, National Cancer Center Hospital East, Department of Gastroenterology and Gastrointestinal Oncology, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
March 2012

S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.

Jpn J Clin Oncol 2011 Dec 5;41(12):1351-7. Epub 2011 Oct 5.

Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo Nagaizumi Sunto-gun, Shizuoka 411-8777, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyr147DOI Listing
December 2011

Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing.

Brain Tumor Pathol 2011 Apr 23;28(2):115-23. Epub 2011 Feb 23.

Department of Neurosurgery, Institute of Clinical Medicine,University of Tsukuba, 1-1-1 Tennoudai, Tsukuba,Ibaraki 305-8575, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10014-011-0023-7DOI Listing
April 2011

Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation.

Biochem Biophys Res Commun 2011 Mar 23;406(4):608-13. Epub 2011 Feb 23.

Molecular Tumor Marker Research Team, The Oncology Research Center, Advanced Molecular Epidemiology Research Institute, Yamagata University Faculty of Medicine, 2-2-2 Iida-nishi, Yamagata 990-9585, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2011.02.102DOI Listing
March 2011

Tumor KRAS status predicts responsiveness to panitumumab in Japanese patients with metastatic colorectal cancer.

Jpn J Clin Oncol 2011 Feb 17;41(2):210-6. Epub 2010 Dec 17.

National Cancer Center Hospital East, Gastrointestinal/Oncology Division, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba-ken 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyq229DOI Listing
February 2011

Weekly Paclitaxel after failure of gemcitabine in pancreatic cancer patients with malignant ascites: a retrospective study.

Jpn J Clin Oncol 2010 Dec 22;40(12):1135-8. Epub 2010 Jul 22.

Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007, Nagaizumi, Shizuoka 411-8777, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyq117DOI Listing
December 2010

Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer.

Jpn J Clin Oncol 2010 Nov 5;40(11):1014-20. Epub 2010 Jul 5.

Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyq104DOI Listing
November 2010

[Lower G. I./colon and rectum cancer. III. Current topics concerning postoperative adjuvant chemotherapy].

Gan To Kagaku Ryoho 2010 Nov;37(11):2080-4

View Article

Download full-text PDF

Source
November 2010

S-1 monotherapy as second-line treatment for advanced pancreatic cancer after gemcitabine failure.

Jpn J Clin Oncol 2010 Jun 26;40(6):567-72. Epub 2010 Feb 26.

Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyq005DOI Listing
June 2010